T-116_Procera-Bridge Zirconia - A Clinical Study
- Conditions
- Partial Edentulism
- Registration Number
- NCT02186808
- Lead Sponsor
- Nobel Biocare
- Brief Summary
The objective of the study is to evaluate the clinical performance of Procera® Bridge Zirconia veneered with NobelRondo Zirconia.
- Detailed Description
The study was designed to be an open, 5-year, prospective, multi-center clinical post-market study. The objectives of this clinical study were that industrial centrally produced 3- or 4-unit bridges of yttrium-oxide partially-stabilized (Y-TZP) zirconia (Procera Zirconia) in combination with the veneering ceramic material NobelRondo will show sufficient CDA ratings (90% R+S) and a sufficient survival rate after 1 and 5 years.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- Patients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible
- Indication: same indication as for metal supported bridges
- Obtained informed consent from the patient
Exclusion criteria
- Currently known alcohol, drug or medication abuse, judged by the investigator, which might influence the follow-up program
- Patients where a bridge part connection area of 3 mm of diameter is not possible to obtain (short clinical crowns)
- Mobility of the abutment teeth exceeding grade I
- Patients with pathologic pocket formation at abutment teeth
- Patients with complete dentures in the opposing jaw
- Patients with a removable partial denture in the same jaw
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Success Rate of Bridge Procera Bridge Zirconia prosthesis delivery, 1 year The CDA index (1) is Romeo or Sierra at delivery and remains so up to 1 year post loading.
- Secondary Outcome Measures
Name Time Method Success Rate of Bridge Procera Bridge Zirconia prosthesis delivery, 5 years The CDA index (1) is Romeo or Sierra at delivery and remains so 5 year post loading.